Paola Parra Ramirez
Overview
Explore the profile of Paola Parra Ramirez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
109
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Valderrabano P, Quinones Silva J, Campos Mena S, Familiar Casado C, de Miguel Novoa M, Sanabria Perez M, et al.
Eur Thyroid J
. 2025 Feb;
14(1).
PMID: 39960816
Objective: To evaluate the current quality of thyroid ultrasound reports in the Community of Madrid. Methods: Consecutive thyroid ultrasound reports from patients evaluated in the endocrine outpatient clinics of eight...
2.
Lamas C, Araujo-Castro M, Ostermair L, Petersenn E, Parra Ramirez P, Rebollo-Roman A, et al.
Biomedicines
. 2024 Nov;
12(11).
PMID: 39594996
: Mild autonomous cortisol secretion (MACS) can coexist with primary aldosteronism (PA). The purpose of our study was to evaluate whether (MACS) influences parameters analyzed during adrenal venous sampling (AVS)...
3.
Araujo-Castro M, Paja Fano M, Gonzalez-Boillos M, Pascual-Corrales E, Parra Ramirez P, Martin Rojas-Marcos P, et al.
Eur J Endocrinol
. 2024 Nov;
191(6):579-587.
PMID: 39556770
Aim: To evaluate the influence of smoking on cardiometabolic profile and surgical outcomes in patients with primary aldosteronism (PA). Methods: Multicentre retrospective study of patients with PA evaluated in 36...
4.
Araujo-Castro M, Parra Ramirez P, Hanzu F
Endocrinol Diabetes Nutr (Engl Ed)
. 2024 Oct;
71(8):355-364.
PMID: 39374998
Primary hyperaldosteronism (PH) is the most common cause of secondary hypertension (HTN) and is associated with a higher cardiometabolic risk than essential HTN. Nevertheless, PH remains clearly underdiagnosed. An early...
5.
Araujo-Castro M, Ruiz-Sanchez J, Gonzalvo C, Lamas C, Parra Ramirez P, Martin Marcos-Rojas P, et al.
J Clin Endocrinol Metab
. 2024 Jul;
PMID: 39058909
Purpose: To determine the rate of genetic testing for familial hyperaldosteronism (FH) in the SPAIN-ALDO Registry and to describe the clinical characteristics of patients with FH. In addition, a literature...
6.
Araujo-Castro M, Paja Fano M, Gonzalez-Boillos M, Pascual-Corrales E, Martin Rojas-Marcos P, Garcia-Cano A, et al.
J Hypertens
. 2024 Jul;
42(10):1805-1812.
PMID: 39051487
Aim: To evaluate the impact of aldosterone excess on renal function in individuals with primary aldosteronism and to compare its evolution after surgery or mineralocorticoid receptor antagonist (MRA) treatment. Methods:...
7.
Araujo-Castro M, Ruiz-Sanchez J, Parra Ramirez P, Martin Rojas-Marcos P, Aguilera-Saborido A, Gomez Cerezo J, et al.
Endocrine
. 2024 Mar;
85(2):532-544.
PMID: 38507182
Primary aldosteronism (PA) is the most frequent cause of secondary hypertension and is associated with a higher cardiometabolic risk than essential hypertension. The aim of this consensus is to provide...
8.
Araujo-Castro M, Ruiz-Sanchez J, Parra Ramirez P, Martin Rojas-Marcos P, Aguilera-Saborido A, Gomez Cerezo J, et al.
Endocrine
. 2024 Mar;
85(1):99-121.
PMID: 38448679
Primary aldosteronism (PA) is the most frequent cause of secondary hypertension (HT), and is associated with a higher cardiometabolic risk than essential HT. However, PA remains underdiagnosed, probably due to...
9.
Ruiz-Garcia C, Rodriganez Riesco L, Mateos-Serrano B, Bernaldez Millan R, Del Palacio Munoz A, Gavilan J, et al.
Acta Otorrinolaringol Esp (Engl Ed)
. 2024 Feb;
75(4):224-230.
PMID: 38346491
Background And Objective: Nodal metastases in the central compartment are frequent in papillary thyroid cancer (PTC). However, they are mostly micrometastases with no impact on survival and their relevance on...
10.
Vivancos Sanchez C, Navia Alvarez P, Alfonso Carrillo C, Parra Ramirez P, Perez Lopez C
Endocrinol Diabetes Nutr (Engl Ed)
. 2024 Feb;
71(1):35-37.
PMID: 38326177
No abstract available.